CLDN1 regulates trophoblast apoptosis and proliferation in preeclampsia. Issue 6 (5th May 2021)

• Record Type: Journal Article
• Authors: Zhang, Yu-chen; Qin, Xiao-li; Ma, Xiao-ling; Mo, Hui-qin; Qin, Shi; Zhang, Cheng-xi; Wei, Xiao-wei; Liu, Xue-qing; Zhang, Yan; Tian, Fu-ju; Lin, Yi
• Is Part Of: Reproduction. Volume 161:Issue 6(2021)
• Page Start: 623
• Page End: 632
• Publication Date: 2021-05-05
• Subjects: Reproduction -- Periodicals; Reproduction -- Molecular aspects -- Periodicals; Reproduction -- Immunological aspects -- Periodicals; Reproduction -- Endocrine aspects -- Periodicals; Fertility -- Periodicals; Human reproduction -- Periodicals; 571.805
• DOI: 10.1530/REP-20-0677
• Languages: English
• ISSNs: 1470-1626

Abstract

Abstract : Preeclampsia is a gestational hypertensive disease; however, preeclampsia remains poorly understood. Bioinformatics analysis was applied to find novel genes involved in the pathogenesis of preeclampsia and identified CLDN1 as one of the most differentially expressed genes when comparing patients with preeclampsia and healthy controls. The results of the qRT-PCR, Western blotting and immunohistochemistry experiments demonstrated that CLDN1 was significantly downregulated in the chorionic villi in samples from patients with preeclampsia. Furthermore, knockdown of CLDN1 in HTR-8/SVneo cells resulted in the inhibition of proliferation and induction of apoptosis, and overexpression of CLDN1 reversed these effects. In addition, RNA-seq assays demonstrated that the gene BIRC3 is potentially downstream of CLDN1 and is involved in the regulation of apoptosis. Knockdown of CLDN1 confirmed that the expression level of BIRC3 was obviously decreased and was associated with a significant increase in cleaved PARP. Interestingly, the apoptotic effect in CLDN1 knockdown cells was rescued after BIRC3 overexpression. Overall, these results indicate that a decrease in CLDN1 inhibits BIRC3 expression and increases cleaved PARP levels thus participating in the pathogenesis of preeclampsia.